Literature DB >> 26883899

Single-catheter approach to pulmonary vein reisolation in selected patients : Data from a prospective registry.

J Lauschke1, R Schneider2, J Wissmann2, T Tischer2, D Bänsch2.   

Abstract

BACKGROUND: In addition to different types of single-tip ablation catheters for pulmonary vein (PV) reisolation, a newly developed circular mapping and ablation catheter (nMARQ®) has been available since 2013 and is currently used only in initial PV isolation procedures. In this prospective registry we present feasibility and efficacy data for PV reisolation procedures with a single-catheter approach (nMARQ®) compared with a standard approach using a single-tip ablation catheter and a circular mapping catheter.
METHODS: We included 35 carefully selected patients in this prospective registry and assigned them in a 2:1 ratio to undergo either PV reisolation with a single-tip ablation catheter together with a steerable circular mapping catheter (group 1) or with the nMARQ®catheter only (group 2). The recurrence rate was calculated for atrial tachyarrhythmias with a duration of > 30 s during a mean follow-up of 12.7 months.
RESULTS: Reisolation of all PVs was achieved in all patients of both groups. In group 2, all gaps could be correctly identified with the nMARQ® catheter. PV isolation was clearly visible on the nMARQ® catheter in all targeted veins. With the nMARQ® catheter the ablation time decreased significantly (6.3 ± 3.0 vs. 18.6 ± 13.9 min, p < 0.05). The recurrence rate of atrial fibrillation did not differ significantly between the two groups (37.5 vs. 45.5 %, p = 0.66).
CONCLUSION: In selected patients, a complete PV reisolation procedure is feasible with a singular circular mapping and ablation catheter. The 12-months success rate is comparable to a classic approach with a combination of a single-tip ablation catheter and a circular mapping catheter.

Entities:  

Keywords:  Atrial fibrillation; Circular mapping catheter; Pulmonary vein reisolation; Single-tip catheter; nMARQ®

Mesh:

Year:  2016        PMID: 26883899     DOI: 10.1007/s00059-016-4402-z

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  10 in total

1.  Radiofrequency ablation of paroxysmal atrial fibrillation with the new irrigated multipolar nMARQ ablation catheter: verification of intracardiac signals with a second circular mapping catheter.

Authors:  Raphael Rosso; Amir Halkin; Yoav Michowitz; Bernard Belhassen; Aharon Glick; Sami Viskin
Journal:  Heart Rhythm       Date:  2013-12-30       Impact factor: 6.343

2.  Pulmonary vein isolation with a new multipolar irrigated radiofrequency ablation catheter (nMARQ™): feasibility, acute and short-term efficacy, safety, and impact on postablation silent cerebral ischemia.

Authors:  Marco Scaglione; Domenico Caponi; Matteo Anselmino; Francesca Di Clemente; Alessandro Blandino; Federico Ferraris; Paolo Di Donna; Elisa Ebrille; Franck Halimi; Jean F Leclercq; Costanza Iunco; Carloeugenio Vaudagna; Federico Cesarani; Fiorenzo Gaita
Journal:  J Cardiovasc Electrophysiol       Date:  2014-09-14

3.  Safety and efficacy of pulmonary vein isolation using a circular, open-irrigated mapping and ablation catheter: A multicenter registry.

Authors:  Giuseppe Stabile; Ermenegildo De Ruvo; Massimo Grimaldi; Giovanni Rovaris; Ezio Soldati; Matteo Anselmino; Francesco Solimene; Assunta Iuliano; Luigi Sciarra; Vincenzo Schillaci; Maria Grazia Bongiorni; Fiorenzo Gaita; Leonardo Calò
Journal:  Heart Rhythm       Date:  2015-05-22       Impact factor: 6.343

4.  Phrenic nerve lesion: a potential complication of the nMARQ ablation technique.

Authors:  José David Arroja; Marc Zimmermann
Journal:  Int J Cardiol       Date:  2014-11-26       Impact factor: 4.164

5.  Mapping and ablation of a left atrial macro reentrant tachycardia originating from the left superior pulmonary vein.

Authors:  J Lauschke; R Schneider; D Bänsch
Journal:  Herz       Date:  2014-03-09       Impact factor: 1.443

6.  Modified energy settings are mandatory to minimize oesophageal injury using the novel multipolar irrigated radiofrequency ablation catheter for pulmonary vein isolation.

Authors:  Andreas Rillig; Tina Lin; Andre Burchard; Masashi Kamioka; Christian Heeger; Hisaki Makimoto; Andreas Metzner; Erik Wissner; Peter Wohlmuth; Feifan Ouyang; Karl-Heinz Kuck; Roland Richard Tilz
Journal:  Europace       Date:  2014-10-23       Impact factor: 5.214

7.  Initial results of using a novel irrigated multielectrode mapping and ablation catheter for pulmonary vein isolation.

Authors:  Dong-In Shin; Kiriakos Kirmanoglou; Christian Eickholt; Jan Schmidt; Lukas Clasen; Britta Butzbach; Tienush Rassaf; Marc Merx; Malte Kelm; Christian Meyer
Journal:  Heart Rhythm       Date:  2013-12-07       Impact factor: 6.343

8.  nMARQ Ablation for Atrial Fibrillation: Results from a Multicenter Study.

Authors:  Saagar Mahida; Darren A Hooks; Karin Nentwich; G Andre Ng; Massimo Grimaldi; Dong-In Shin; Nicolas Derval; Frederic Sacher; Benjamin Berte; Seigo Yamashita; Arnaud Denis; Mélèze Hocini; Thomas Deneke; Michel Haissaguerre; Pierre Jais
Journal:  J Cardiovasc Electrophysiol       Date:  2015-06-16

9.  Acute safety and efficacy of a novel multipolar irrigated radiofrequency ablation catheter for pulmonary vein isolation.

Authors:  Thomas Deneke; Anja Schade; Patrick Müller; Rainer Schmitt; Georgios Christopoulos; Joachim Krug; Geza Szöllösi; Andreas Mügge; Sebastian Kerber; Karin Nentwich
Journal:  J Cardiovasc Electrophysiol       Date:  2013-12-04

10.  Pulmonary vein isolation using a circular, open irrigated mapping and ablation catheter (nMARQ): a report on feasibility and efficacy.

Authors:  Stephan Zellerhoff; Matthew Daly; Han S Lim; Arnaud Denis; Yuki Komatsu; Laurence Jesel; Nicolas Derval; Frédéric Sacher; Hubert Cochet; Sébastien Knecht; Sunthareth Yiem; Mélèze Hocini; Michel Haïssaguerre; Pierre Jaïs
Journal:  Europace       Date:  2014-06-18       Impact factor: 5.214

  10 in total
  2 in total

1.  Direct results of a prospective randomized study comparing ablation with the nMARQ catheter and the PVAC catheter used with and without a 3D system (MAPER 3D Study).

Authors:  Edward Koźluk; Agnieszka Piątkowska; Dariusz Rodkiewicz; Michał Peller; Janusz Kochanowski; Grzegorz Opolski
Journal:  Arch Med Sci       Date:  2017-05-30       Impact factor: 3.318

2.  Atrial Fibrillation Recurrence and Peri-Procedural Complication Rates in nMARQ vs. Conventional Ablation Techniques: A Systematic Review and Meta-Analysis.

Authors:  Ka H C Li; Mei Dong; Mengqi Gong; George Bazoukis; Ishan Lakhani; Yan Y Ting; Sunny H Wong; Guangping Li; William K K Wu; Vassilios S Vassiliou; Martin C S Wong; Konstantinos Letsas; Yimei Du; Victoria Laxton; Bryan P Yan; Yat S Chan; Yunlong Xia; Tong Liu; Gary Tse
Journal:  Front Physiol       Date:  2018-05-22       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.